Dec 2023 $47 M No. 5 $10 to $50 million 9
NewLeaf Symbiotics, Inc.: Raise no. 5, Dec 2023 × Investors in this round 9 investors had bought by the notice of Dec 21, 2023: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $47 M of $47 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Aaron Kelley · Executive Officer Brent Smith · Executive Officer, Director David Flack · Executive Officer David Purschke · Executive Officer Michael Frodyma · Executive Officer Molly Edwards · Executive Officer Natalie Breakfield · Executive Officer Shawn Semones · Executive Officer Stephen Kahn · Executive Officer, Director David Prend · Director John Pasquesi · Director Paul Schickler · Director Sanjeev Krishnan · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Molly Edwards, General Counsel and Vice President of Human Resources. Source: SEC Form D, newest notice filed Dec 21, 2023. Read the notice at the SEC .
equity SEC Feb 2020 $21 M No. 4 $10 to $50 million 6
NewLeaf Symbiotics, Inc.: Raise no. 4, Feb 2020 × Investors in this round 6 investors had bought by the notice of Feb 25, 2020: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $21 M of $35 M offered; $14 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees $150,000
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Aaron Kelley · Executive Officer Desmond Jimenez · Executive Officer Janne Kerovuo · Executive Officer Matt Helms · Executive Officer Molly Edwards · Executive Officer Natalie Breakfield · Executive Officer Stephen Kahn · Executive Officer, Director David Prend · Director John Pasquesi · Director Paul Schickler · Director Sanjeev Krishnan · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Pickwick Capital Partners, LLC (CRD 130672) · White Plains, New York Sold in CA, IL, MA, MO, NC, NY Remarks in the notice On fees: “Finders' fees paid in connection with sales through February 14, 2020.”Signed by Stephen Kahn, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 25, 2020. Read the notice at the SEC .
equity SEC Jun 2017 $24 M No. 3 $10 to $50 million 15
NewLeaf Symbiotics, Inc.: Raise no. 3, Jun 2017 × Investors in this round 15 investors had bought by the notice of Jul 10, 2017: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $24 M of $30 M offered; $6 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Desmond Jimenez · Executive Officer Doug Bryant · Executive Officer Janne Kerovuo · Executive Officer Michael McFatrich · Executive Officer Stephen Kahn · Executive Officer Thomas Laurita · Executive Officer, Director John Pasquesi · Director Stoddard Wilson · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas Laurita, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 10, 2017. Read the notice at the SEC .
equity SEC Sep 2014 $17 M No. 2 $10 to $50 million 16
NewLeaf Symbiotics, Inc.: Raise no. 2, Sep 2014 × Investors in this round 16 investors had bought by the notice of Sep 15, 2014: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $17 M of $17 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Desmond Jimenez · Executive Officer Doug Bryant · Executive Officer Gregg Bogosian · Executive Officer Stephen Kahn · Executive Officer, Director Thomas Laurita · Executive Officer, Director Todd Mockler · Executive Officer Daniel Hullah · Director Jason Wrone · Director Keith Gillard · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Stephen Kahn, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 15, 2014. Read the notice at the SEC .
equity SEC Jan 2013 $5 M No. 1 $2 to $10 million 4
NewLeaf Symbiotics, Inc.: Raise no. 1, Jan 2013 × Investors in this round 4 investors had bought by the notice of Jan 18, 2013: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $6 M offered; $1 M still to sell
Smallest investment taken $50,000
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $316,250
Finders' fees none
Paid to its own people $316,250 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions and payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Marc Vanacht · Executive Officer, Director Marcus Jones · Executive Officer Stephen Kahn · Executive Officer Thomas Laurita · Executive Officer, Director Mel Schuster · Director Michael Bielski · Director Richard Carlton · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Prevail Capital LLC (CRD 141322) · Bedford, Massachusetts Sold in IL, MA Remarks in the notice On the use of proceeds: “Stephen Kahn, an executive officer, is a principal of Prevail Capital LLC.”Signed by Stephen Kahn, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 18, 2013. Read the notice at the SEC .
equity, options SEC